How Africa defeated meningitis A
The MenAfriVac vaccine has eliminated the leading cause of bacterial meningitis in Africa. A new vaccine covering other major strains could be a further game-changer.
Stay updated with breaking news from Marc Laforce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The MenAfriVac vaccine has eliminated the leading cause of bacterial meningitis in Africa. A new vaccine covering other major strains could be a further game-changer.
/PRNewswire/ -- The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd November at the...
/PRNewswire/ -- According to an official announcement made in Dubai, three American scientists are among the winners of the International Awards given by the...
The World Health Organization is warning of a resurgence of deadly meningitis in Africa because COVID-19 has disrupted lifesaving vaccination campaigns. The near elimination of the deadly form of meningitis type A in Africa is one of the continent’s biggest health success stories. Over the last 12 years, about 350 million Africans have received a…
Download logoWith the COVID-19 pandemic delaying meningitis vaccination campaigns for more than 50 million children in Africa, the region is at a